Nausea, vomiting, constipation, and decreased appetite are common, particularly during the first weeks and during dose increases
Clinical therapeutic effects and challenges of GLP-1 receptor agonists The primary GLP-1RAs used worldwide as anti-obesity drugs are liraglutide (Saxenda, Novo Nordisk) as a once-daily subcutaneous injection and semaglutide (Wegovy, Novo Nordisk) as a once-weekly subcutaneous injection
La seleccin debe basarse en el perfil individual del paciente, comorbilidades y preferencias
Acid Reflux and Heartburn Because food stays in the stomach longer, the acid required to break down that food also sticks around
Oral vs Injectable GLP-1: Complete Format Comparison for 2026 With Wegovy Pill and Foundayo now available, patients can choose between daily pills and weekly injections